Purchase Order 75N91023P00866
Award Date 9/12/23
Potential Completion Date 10/12/23
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pasadena, CA 91107, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $175,000.00 firm fixed price purchase order to De Novo Software LLC, a self-certified small disadvantaged business, for de novo image cytometry analysis software. The contract has a completion date of September 13, 2022 and does not have a set-aside designation. The contract was awarded in response to a pre-solicitation notice for an advanced image analysis module upgrade to...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at fourteen thousand four hundred ninety dollars to Certara USA Inc. for software licenses. Certara will provide the licenses to the NIH NCI in support of its mission to conduct and coordinate research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer,...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,000 firm fixed price purchase order to Caerus US 1 Inc. for SOFTWARE. The place of performance is New York, NY. The one year contract starts on July 26, 2023 and ends on July 25, 2024. No set aside designation or subcontractors were identified. The National Cancer Institute is a part of NIH focused on cancer research, so this contract is likely to deliver software products or...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,833 firm fixed price purchase order to Scientific Volume Imaging B.V. Sales Department Division to upgrade the Huygens software. The prime contractor will deliver the requested software upgrade under the contract, which has a period of performance from July 1, 2023 through July 31, 2024 at the place of performance in Bethesda, Maryland. The National Cancer Institute seeks to...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $25,000 purchase order to Revvity Signals Software, Inc. Informatics Division for SOFTWARE. The prime contractor will deliver the requested software products and services over a one-year period of performance from August 1, 2023 through July 31, 2024 under a firm fixed price contract. Revvity Signals Software, Inc. Informatics Division is a subsidiary of Revvity Inc. Medical Imaging, LLC...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $42,551.84 firm fixed price delivery order against the Chief Information Officer Commodities and Solutions (CIO-CS) government-wide acquisition contract to New TECH Solutions, Inc. for software. The delivery order has a period of performance through February 2025 and was awarded on February 15, 2024 without a set aside designation. New TECH Solutions, Inc. will provide the software...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $10,869.60 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for ILAB OPERATIONS SOFTWARE COVERAGE. The prime contractor, Agilent Technologies Inc., will provide software coverage in support of the Institute's operations through November 2024. Performance will take place in Bethesda, Maryland. No set aside designation or subcontractors...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,400 firm fixed price purchase order to Thermo Electron North America LLC, doing business as Thermofisher Scientific, for software. The contract has a period of performance through January 21, 2025 with no set-aside designation utilized. Thermofisher Scientific will provide unspecified software to the National Cancer Institute to support its biomedical research mission under this...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,200 purchase order to Dnastar, Inc. for DNASTAR LASERGENE SITE LICENSE RENEWAL covering the period from August 1, 2023 through July 31, 2024. Under this firm fixed price contract, Dnastar, Inc. will provide DNA analysis software licensing and support to the NIH organization. No subcontractors or set aside designations were identified. This type of...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $191,168.97 firm fixed price delivery order to New TECH Solutions, Inc. for software renewal. The contract was awarded under the Chief Information Officer Commodities and Solutions government-wide acquisition contract vehicle, which provides information technology commodities and solutions to federal agencies. New TECH Solutions, Inc. will perform the work as the prime contractor in...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,080 purchase order to De Novo Software LLC of Pasadena, California for a SOFTWARE LICENSE. The firm fixed price contract is to deliver the licensed software between September 12, 2023 and October 12, 2023 to support the National Cancer Institute's research programs. No subcontractors or set aside designations were identified. De Novo Software will provide the software license to the National Institutes of Health to support their efforts advancing cancer research and related biomedical sciences.
Generated 12/18/23, 10:41 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 9/7/23 |